Advertisements

Lpath Inc. (LPTN) Stock Quote

Detailed Quote for Lpath Inc. (LPTN)
$ 2.42   -0.06 (-2.42%) Volume: 17.63k 9:50 AM EDT Mar 30, 2015
Today 5d 1m 3m 1y more
Last Price
2.42
Change $
0.06
Change %
2.42%
Tick
  
Bid
2.42
Bid Size
5,000
Ask
2.48
Ask Size
200
Open
2.43
High
2.4568
Low
2.40
Prev Close
2.48
Last Trade
9:50
Volume
17.63k
52 Wk Hi
4.79
52 Wk Low
2.22
Market Cap
46.76m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
19,321,256
EPS (TTM)
-1.00
PE Ratio
N/A
Exchange
NCM
News and Media for Lpath Inc. (LPTN)
Sector News | Topic News
News for Lpath Inc. (LPTN)
Wed, Mar 25, 2015
12:45 PM Midday Gainers / Losers - SeekingAlpha
Tue, Mar 24, 2015
5:34 PM Lpath kidney cancer drug candidate fails in study; shares off 27% after hours - SeekingAlpha
4:00 PM Lpath Reports Results for ASONEP Phase 2a Study in Renal Cell Carcinoma - PR Newswire
Mon, Mar 23, 2015
8:41 AM Lpath to Hold Investor Update Conference Call - PR Newswire
Wed, Mar 11, 2015
2:41 PM Cleveland BioLabs: A Reverse Split Low Floater With Catalysts - SeekingAlpha
8:00 AM Lpath to Submit Additional Data for Lpathomab Investigational New Drug Application - PR Newswire
Sat, Mar 07, 2015
6:15 AM Lpath: A Binary Situation With Odds In Investors' Favor - SeekingAlpha
Mon, Feb 02, 2015
8:00 AM Lpath Submits Investigational New Drug Application for Lpathomab for Neuropathic Pain - PR Newswire
Tue, Dec 02, 2014
4:05 PM Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration - PR Newswire
Tue, Nov 04, 2014
4:30 PM Lpath Announces Departure Of CEO - PR Newswire
Mon, Oct 20, 2014
8:00 AM Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs - PR Newswire
Tue, May 27, 2014
9:52 PM Is Lpath Inc. a Savior from Blindness? - Equities.com
Thu, Oct 17, 2013
8:52 AM Five Star Equities Issues New Research Reports on ARIA, CGIX, CYTR and LPTN - Accesswire
Thu, Mar 01, 2012
7:19 AM Keeping an eye on Lpath as shares look to build momentum - Accesswire
Tue, Dec 06, 2011
11:13 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
11:06 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
Thu, Dec 01, 2011
2:11 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
2:10 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
More News for LPTN >>

Tags for Lpath Inc.

Research stocks or mutual funds related to Lpath Inc. by keywords or tags. Find companies that have a similar focus to LPTN. The keywords below have been associated to LPTN by either user submission or electronic means.

microcurrent macular degeneration clinical trials database human monoclonal antibody clinical research trial clinical development clinical cost antibody protein clinical pharmacology cv therapeutics stock clinical research consulting outsourcing clinical trials angiogenesis inhibitors Biological Products corporate governance clinical investigators cra clinical research cv therapeutics clinical research clinical research investigators board of directors role clinical trials manager board of directors governance board compensation antibodies directors duties board governance human antibodies Drugs monospecific antibodies pain therapeutics cardiology clinical trials clinical trials conference board of directors info medical device clinical trial cedra clinical research board of directors compensation board of directors responsibility cellegy pharmaceuticals international clinical trials board responsibilities clinical data medical trials monoclonal antibody Healthcare corporate governance board of directors monitoring clinical research clinical research guidelines clinical outsourcing clinical research investigator monospecific antibody